Park Avenue Securities’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.22M Sell
53,905
-49,311
-48% -$3.98M 0.03% 425
2026
Q1
$8.94M Buy
+103,216
New +$9.89M 0.07% 217
2025
Q4
Sell
-47,057
Closed -$4.48M 1633
2025
Q3
$4.48M Buy
47,057
+3,830
+9% +$352K 0.04% 347
2025
Q2
$3.77M Sell
43,227
-6,329
-13% -$537K 0.03% 334
2025
Q1
$4.45M Buy
49,556
+10,462
+27% +$936K 0.05% 220
2024
Q4
$3.12M Buy
39,094
+14,101
+56% +$1.22M 0.03% 336
2024
Q3
$2.25M Buy
24,993
+809
+3% +$68.1K 0.03% 401
2024
Q2
$1.9M Sell
24,184
-22,580
-48% -$1.85M 0.02% 431
2024
Q1
$4.08M Buy
46,764
+7,841
+20% +$669K 0.05% 234
2023
Q4
$3.21M Sell
38,923
-24,954
-39% -$1.9M 0.04% 251
2023
Q3
$5M Buy
63,877
+2,793
+5% +$234K 0.08% 159
2023
Q2
$5.38M Buy
61,084
+10,272
+20% +$884K 0.09% 157
2023
Q1
$4.1M Buy
50,812
+4,162
+9% +$339K 0.07% 175
2022
Q4
$3.63M Buy
46,650
+2,830
+6% +$229K 0.06% 190
2022
Q3
$3.54M Buy
43,820
+2,486
+6% +$223K 0.07% 169
2022
Q2
$3.71M Buy
41,334
+5,247
+15% +$532K 0.07% 168
2022
Q1
$4M Buy
36,087
+3,863
+12% +$408K 0.07% 155
2021
Q4
$3.33M Buy
32,224
+909
+3% +$105K 0.06% 187
2021
Q3
$3.92M Buy
31,315
+2,225
+8% +$288K 0.08% 130
2021
Q2
$3.61M Sell
29,090
-423
-1% -$53.1K 0.08% 132
2021
Q1
$3.49M Buy
29,513
+3,355
+13% +$393K 0.08% 120
2020
Q4
$3.06M Buy
26,158
+1,613
+7% +$178K 0.09% 108
2020
Q3
$2.55M Buy
24,545
+2,161
+10% +$217K 0.09% 108
2020
Q2
$2.05M Buy
22,384
+2,409
+12% +$231K 0.08% 112
2020
Q1
$1.8M Buy
19,975
+2,830
+17% +$301K 0.15% 59
2019
Q4
$1.95M Buy
17,145
+1,535
+10% +$168K 0.08% 105
2019
Q3
$1.7M Sell
15,610
-1,379
-8% -$144K 0.08% 100
2019
Q2
$1.66M Buy
16,989
+4,191
+33% +$383K 0.19% 46
2019
Q1
$1.16M Buy
12,798
+3,595
+39% +$322K 0.06% 112
2018
Q4
$781K Buy
9,203
+1,421
+18% +$133K 0.12% 61
2018
Q3
$774K Buy
7,782
+1,346
+21% +$124K 0.12% 59
2018
Q2
$554K Sell
6,436
-1,398
-18% -$117K 0.1% 71
2018
Q1
$607K Buy
7,834
+3,789
+94% +$313K 0.13% 50
2017
Q4
$333K Buy
4,045
+488
+14% +$39.1K 0.09% 75
2017
Q3
$278K Sell
3,557
-474
-12% -$39.4K 0.09% 68
2017
Q2
$375K Buy
+4,031
New +$340K 0.04% 99
2017
Q1
Sell
-3,326
Closed -$235K 63
2016
Q4
$235K Buy
3,326
+298
+10% +$23.4K 0.12% 43
2016
Q3
$262K Buy
3,028
+262
+9% +$22.8K 0.15% 31
2016
Q2
$241K Buy
+2,766
New +$224K 0.04% 73

Other funds holding MDT

Park Avenue Securities's MDT Position: Q2 2026 in Review

Park Avenue Securities reduced its Medtronic (MDT) stake by 48% in Q2 2026, selling an estimated $3.98M and leaving 53,905 shares worth $4.22M. The position accounts for 0.03% of the portfolio, ranked #425.

Park Avenue Securities first reported a position in MDT in Q2 2016 and has held it in 39 quarters since. The position peaked at $8.94M in Q1 2026. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Park Avenue Securities held 53,905 shares of Medtronic worth $4.22M as of Q2 2026.
  • Park Avenue Securities sold 49,311 Medtronic shares in Q2 2026, an estimated $3.98M.
  • Medtronic made up 0.03% of Park Avenue Securities's portfolio in Q2 2026, its #425 holding.
  • Park Avenue Securities first reported a position in Medtronic in Q2 2016 and has held it in 39 quarters since.
  • Park Avenue Securities's Medtronic position peaked at $8.94M in Q1 2026.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.